Evidence
He supports limiting pharmaceutical market exclusivity beyond patent rights to allow generic drugs to be sold sooner.
Their own words or recordStatus: judgedVerified quote
In context
Regarding pharmaceuticals, I would support limiting the term of pharmaceuticals’ market exclusivity, which is determined by the FDA above and beyond patent rights.
From Maad Abu-Ghazalah - North Carolina Health News (northcarolinahealthnews.org), fetched Nov 3, 2026.
Reviews
No human review has been recorded for this claim yet.